Navigation Links
InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
Date:8/6/2008

BRITISH COLUMBIA, Canada, Aug. 6 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (TSX VENTURE: IXS.V; OTC Bulletin Board: IXSBF) (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, today announced the addition of a new product designated DXLr120 (CD20). This is the third product added to the growing InNexus pipeline and was developed using new recombinant methods to produce a DXL(TM) anti CD20 antibody. InNexus' first and second products were developed with chemical methods to impart DXL(TM) into the development of new antibodies and the latest product represents a significant patent expansion for the company.

InNexus Chief Scientific Officer, Dr. Thomas Kindt, said, "Within the past two years, InNexus has moved rapidly to accelerate preclinical development of multiple candidates. Use of recombinant methods to develop DXLr120 with our patented DXL(TM) technology demonstrates the expertise of our team and the opportunity we have to create multiple therapeutic and diagnostic antibodies."

DXLr120 significantly improves antibodies binding to CD20, the target for Non Hodgkin's Lymphoma and Rheumatoid Arthritis and joins InNexus' well-studied DXL625 (CD20). DXL625, developed with chemical methods, also significantly improves the binding of antibodies to CD20 and increases potency using both in vitro and in vivo studies. Preliminary data for DXLr120 already reveals properties akin to those shown for DXL625. Plans are underway to subject DXLr120 to the full battery of tests for potency, in vivo efficacy and safety used for DXL625.

The company will present at IBC's 13th Annual World Congress Drug Discovery & Development of Innovative Therapeutics (DDT) Conference in Boston at the World Trade Center Boston. The InNexus presentation will be within the Main Conference (amphitheat
'/>"/>

SOURCE InNexus Biotechnology Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
2. Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
3. CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
4. Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry
5. NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
6. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
7. BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR
8. Genetic Engineering and Biotechnology News reports on early ADMET use
9. China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention
10. Rigel to Present at 8th Annual Fortis Bank Biotechnology Conference
11. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... Creighton University was named to ... – the highest federal recognition a college or university ... learning and civic engagement as well as meaningful community ... National and Community Service, is given to 690 schools ... at Creighton is based on spiritual growth through service ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 With the ... has put together their winter season Santiago day ... adventure day trips in and around Santiago this season, ... into Chile's Central Andes for backcountry skiing, challenging rock ... those who have always dreamed of skiing in ...
(Date:6/19/2013)... Paleo Burn has finally been released after much ... body they desire with no fad diets, pills, or extreme ... food products, Ken Smith was bold enough to expose the ... automatic, and permanent solution for weight loss. , ... a quick review of Paleo Burn, TotalWellnessCleanse.net believes this guide ...
(Date:6/19/2013)... 20, 2013 Shreya Rangarajan of Roland ... youth summit on the future of medicine. , ... Global Youth Summit on the Future of Medicine and ... School and the state of Maryland at the Summit. ... practice in an environment hard to imagine just a ...
(Date:6/19/2013)... Florida (PRWEB) June 19, 2013 Go Classy ... Clothing Optional Resorts for over 25 Years. These ... nude beaches, nude pools, nude bars and nude hot tubs. ... lifestyle clients alike. When SuperClubs re-branded the resort to ... of the nude side of the Resort fell off dramatically. ...
Breaking Medicine News(10 mins):Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3Health News:Chile Montaña Announces Winter Season Santiago Day Trips 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 3Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 2Health News:Global Youth Summit on The Future of Medicine-Shreya Rangarajan selected to represent Roland Park Country School and The State of Maryland 3Health News:The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours 2
... suicidal thoughts as well, study finds , TUESDAY, June 9 ... bed at 10 p.m. are less apt to become depressed ... much later, recent research shows. , "This study bolsters the ... study author James Gangwisch, an assistant professor of psychiatry at ...
... LANCASTER, Pa., June 9 Herley Industries, Inc. (Nasdaq: ... Lancaster division received a contract award valued at approximately ... manufacture complex Integrated Microwave Assemblies (IMA) for an electronic ... Herley Chairman and CEO, Myron Levy, said, "Herley has ...
... professional pilots for example, depend on good vision as ... not required to undergo regular vision testing. A new ... they don,t recall ever having their vision tested or ... last vision exam. The study, performed at ...
... This release is available in French . ... antifungals are seeping into the waterways of North America, ... in the peer-reviewed journal Environmental Health Perspectives ... researchers, the review found that consumption of anti-infectives for ...
... unions, and veteran political leaders announces support for ... improve outcomes and reduce health care costs for ... support bipartisan reform agreement in Congress , ... an organization bringing together an expanding alliance of ...
... First Sugar-Free Functional Beverage Made Specifically for Kids, Over Soda ... WAT-AAH!, the first sugar-free functional beverage brand made specifically for ... their first nationwide WAT-AAH! Challenge to defy the expectation that ... over water. , , During the months of ...
Cached Medicine News:Health News:Early Bedtime May Help Stave Off Teen Depression 2Health News:Early Bedtime May Help Stave Off Teen Depression 3Health News:Herley Receives a $1.2 Million Contract Award for Complex Integrated Microwave Assemblies for U.S. Electronic Attack Aircraft 2Health News:Antibiotics, antimicrobials and antifungals in waterways 2Health News:Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform 2Health News:Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform 3Health News:Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform 4Health News:Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform 5Health News:Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform 6Health News:Businesses, Unions, Veteran Party Leaders Unite Behind Bipartisan, Consensus Approach to Health Care Reform 7Health News:Let Water Be Water, LLC Announces Results of the 'WAT-AAH! Challenge' 2
(Date:6/20/2013)... June 20, 2013 Today Moscamed made ... launch of a new programme to control the dengue mosquito ... the State of Bahia. In previous trials Moscamed ... to rapidly reduce the number of dengue mosquitoes in a ... of these mosquitoes were reduced by 96% within 6 months ...
(Date:6/19/2013)... Calif. , June 19, 2013 Pharmacyclics, ... announced that The New England Journal of Medicine ... 2 study evaluating the investigational oral Bruton,s tyrosine kinase ... lymphoma (MCL) online. These data suggested ibrutinib may be ... Results of a separate study examining ...
(Date:6/19/2013)... , June 19, 2013  Haemonetics Corporation ... important developments in the pursuit of its previously ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) , Haemonetics has ... for the future production of medical devices currently ... is a leading global provider of integrated manufacturing ...
Breaking Medicine Technology:Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 2Moscamed Launches Urban Scale Project Using Oxitec GM Mosquitoes in Battle Against Dengue 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4
... ORTHOSET Radiopaque Bone Cement consists ... a sterile,ampule containing bone cement ... and a sterile polyethylene bag,containing ... peelable pouch. The interiors of ...
A "doughy" type of bone cement intended for manual application....
... Videoscopes provide superior image quality and ... the camera head with a C-mount ... more light at the operative site ... image clarity and reliability.,The Videoscopes have ...
... OMEGA 180 features a wide range of ... and Variable Pupil Control (U.S. Patent #4,684,227). ... down to 1.2mm. Heine's unique Diffuser aperture ... learning BIO easier, and simplifying difficult examinations. ...
Medicine Products: